Found 21 matching trials
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
PHASE1Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Exenatide for Myocardial Protection During Reperfusion Study
PHASE2This study aims to assess the effect of exenatide on myocardial injury in p...
Location
Foothills Medical Centre
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
NAIncretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Location
Gastroenterology Department Erasme Hospital
The Microvascular Function of GLP-1 and Its Analogues
NAIncretins have become a successful drug target in the repertoire of medicat...
Location
Diabetes and Vascular Center
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
PHASE4The purpose of this investigation is to evaluate whether exenatide, a type ...
Location
Phoenix VA Medical Center
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies
PHASE4The aim of this study is to detail the (mechanisms underlying the) actions ...
Location
VU University Medical Center
Intravenous Exenatide in Patients With Acute Brain Injury
PHASE4The purpose of this study is to assess the feasibility of exenatide infusio...
Location
University of North Carolina; UNC Medical Center
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
N/ATo perform an observational analysis to emulate a target trial (i.e., a hyp...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
PHASE1The primary purpose of this study is to demonstrate the safety of allogenei...
Location
University of Illinois at Chicago
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
PHASE4To study the effects of GLP 1 analogues and DPP 4 inhibitors on newly detec...